Which of the following is antiplatelet drug –
**Core Concept**
The question is testing the student's knowledge of antiplatelet drugs, which are a class of medications that prevent platelet aggregation and blood clot formation. This is crucial in the management of cardiovascular diseases, such as acute coronary syndromes and ischemic stroke.
**Why the Correct Answer is Right**
The correct answer is a drug that works by inhibiting the enzyme cyclooxygenase (COX-1), which is involved in the production of thromboxane A2, a potent platelet aggregator. By inhibiting COX-1, the drug reduces thromboxane A2 production, thereby preventing platelet activation and aggregation. This is a key mechanism by which aspirin exerts its antiplatelet effects.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is a beta-blocker, which works by blocking the effects of epinephrine on the heart, thereby reducing heart rate and contractility. Beta-blockers do not have antiplatelet effects.
**Option B:** This option is incorrect because it is an anticoagulant, which works by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver. Anticoagulants do not prevent platelet aggregation.
**Option C:** This option is incorrect because it is an antihypertensive agent that works by blocking the effects of aldosterone on the kidneys, thereby reducing sodium retention and blood pressure. This class of drugs does not have antiplatelet effects.
**Clinical Pearl / High-Yield Fact**
Remember that aspirin is a non-selective COX inhibitor, which means it also inhibits COX-2, an enzyme involved in pain and inflammation. This is why aspirin can cause gastrointestinal side effects, such as ulcers and bleeding.
**Correct Answer:** D. Aspirin